ACTRN12620001373965尚未招募未知
Investigating the pharmacokinetic shifts of oral creatine supplementation in the third trimester of pregnancy compared to the non-pregnant state.
Monash Medical Centre0 个研究点目标入组 40 人开始时间: 2020年12月22日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomised trial
- 主要目的
- Treatment
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 40 Years（—）
- 性别
- Female
入选标准
- •=/>18 years of age.
- •English speaking and able to give written informed consent
- •No known renal, hepatic, or cardiovascular symptoms.
- •No known gastrointestinal (GIT) disorders affecting absorption from GIT
- •Not consuming known dietary or nutritional supplements containing creatine or protein-based powders
- •Pregnant women only; between 30-34 weeks gestation birthing at the tertiary centre where the trial is being conducted so birthing outcomes can be assessed
排除标准
- •<18 years of age
- •Poor English skills or not proficient in reading English
- •Diabetes Type 1 or 2
- •Known renal disease/hepatic disease
- •Known cardiovascular disease or risk factors for cardiovascular disorders
- •No colitis or any disease affecting absorption and function of the GIT system
- •Taking supplements that may contain creatine or other amino acids
- •Different model of care (not birthing at tertiary centre)
研究者
相似试验
已完成
2 期
Study on the pharmacokinetic interaction between cabazitaxel and darolutamide in metastatic castration-resistant prostate cancer (mCRPC) patients.Metastatic castration-resistant prostate cancer10038597NL-OMON50053Erasmus MC, Universitair Medisch Centrum Rotterdam20
已完成
不适用
Study on the pharmacokinetic interaction between cabazitaxel and darolutamide in metastatic castration-resistant prostate cancer (mCRPC) patients.NL-OMON28448Erasmus MC17
进行中（未招募）
1 期
Study on the interaction between cabazitaxel and darolutamide in patients with metastatic prostate cancermetastatic castration-resistant prostate cancerEUCTR2020-000823-38-NLErasmus MC Cancer Institute17
已完成
Unknown
Efficacy test of the dentifriceot applicableJPRN-UMIN000051611Kao Corporation36
Enrolling By Invitation
1 期
A Pharmacokinetic Comparison of Oral Solution and Tablet Formulations of Favipiravir 200 mg in Healthy Thai Volunteers under Fasting ConditionsTCTR20210903002Chulabhorn Royal Academy24